ERBB2 and breast cancer: Overexpression of human epidermal growth factor receptor (Her)-2 in breast cancer is considered an independent factor for development of brain metastases [1] with up to 37% of patients with Her-2-positive disease relapsing intracranially despite control of extra-cranial metastatic disease [2].